Press releases
- Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
- Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
More ▼
Key statistics
On Friday, Twist Bioscience Corp (0ME:BER) closed at 46.92, -5.95% below its 52-week high of 49.89, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 48.46 |
---|---|
High | 49.00 |
Low | 46.80 |
Bid | 46.19 |
Offer | 46.87 |
Previous close | 48.76 |
Average volume | 151.90 |
---|---|
Shares outstanding | 58.23m |
Free float | 57.21m |
P/E (TTM) | -- |
Market cap | 2.90bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 19:30 BST.
More ▼